Literature DB >> 19543462

.   

Abstract

Year:  2009        PMID: 19543462      PMCID: PMC2692152          DOI: 10.5489/cuaj.1069

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  29 in total

Review 1.  Urologic approaches to metastatic renal cell carcinoma.

Authors:  G H Mickisch
Journal:  Onkologie       Date:  2001-04

Review 2.  Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life.

Authors:  Karl Lesage; Steven Joniau; Karen Fransis; Hein Van Poppel
Journal:  Eur Urol       Date:  2006-10-30       Impact factor: 20.096

3.  Sorafenib in advanced clear-cell renal-cell carcinoma.

Authors:  Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Siebels; Sylvie Negrier; Christine Chevreau; Ewa Solska; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Scott Freeman; Brian Schwartz; Minghua Shan; Ronit Simantov; Ronald M Bukowski
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

4.  Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.

Authors:  Debra A Gervais; Ronald S Arellano; Francis J McGovern; W Scott McDougal; Peter R Mueller
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

5.  Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.

Authors:  F Becker; S Siemer; U Humke; M Hack; M Ziegler; M Stöckle
Journal:  Eur Urol       Date:  2005-12-09       Impact factor: 20.096

6.  Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year.

Authors:  Henry Ho; Christian Schwentner; Richard Neururer; Hannes Steiner; Georg Bartsch; Reinhard Peschel
Journal:  BJU Int       Date:  2008-10-06       Impact factor: 5.588

7.  Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.

Authors:  Allan J Pantuck; Amnon Zisman; Frederich Dorey; Debby H Chao; Ken-Ryu Han; Jonathan Said; Barbara Gitlitz; Arie S Belldegrun; Robert A Figlin
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

8.  Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement.

Authors: 
Journal:  Can Urol Assoc J       Date:  2008-06       Impact factor: 1.862

9.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

10.  A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer.

Authors:  Daniel Y C Heng; Kim N Chi; Nevin Murray; Tao Jin; Jorge A Garcia; Ronald M Bukowski; Brian I Rini; Christian Kollmannsberger
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

View more
  9 in total

1.  Management of kidney cancer: canadian kidney cancer forum consensus update 2011.

Authors:  Mas Jewett; A Finelli; C Kollmannsberger; L Wood; L Legere; J Basiuk; C Canil; D Heng; N Reaume; S Tanguay; M Atkins; G Bjarnason; J Dancey; M Evans; N Fleshner; M Haider; A Kapoor; R Uzzo; D Maskens; D Soulieres; G Yousef; N Basappa; N Bendali; P Black; N Blais; I Cagiannos; M Care; R Chow; H Chung; P Czaykowski; D Derosa; K Durrant; S Ellard; G Farquharson; C Filion-Brulotte; J Gingerich; L Godbout; R Grant; W Hamilton; W Kassouf; G Kurban; K Lane; Jb Lattouf; D Lau; M Leveridge; J McCarthy; R Moore; S North; P O'brien; E Pituskin; P Racine; R Rendon; A So; S Sridhar; K Stubbs; Z Su; L Taylor; T Udall; P Venner; W Vogel; S Yap; P Yau; M Cooper; N Giroux; D Miron; D Mosher; K Ross; J Willacy
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

2.  Canadian guidelines for the management of small renal masses (SRM).

Authors:  Michael A S Jewett; Ricardo Rendon; Louis Lacombe; Pierre I Karakiewicz; Simon Tanguay; Wassim Kassouf; Mike Leveridge; Ilias Cagiannos; Anil Kapoor; Stephen Pautler; Darrel Drachtenberg; Ronald Moore; Martin Gleave; Andrew Evans; Massoom Haider; Antonio Finelli
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

3.  Erratum.

Authors: 
Journal:  Can Urol Assoc J       Date:  2009-08       Impact factor: 1.862

4.  Recent developments in kidney cancer.

Authors:  Michael J Leveridge; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2011-06       Impact factor: 1.862

5.  Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.

Authors:  Sebastien J Hotte; Anil Kapoor; Naveen S Basappa; Georg Bjarnason; Christina Canil; Henry J Conter; Piotr Czaykowski; Jeffrey Graham; Samantha Gray; Daniel Y C Heng; Pierre I Karakiewicz; Christian Kollmannsberger; Aly-Khan A Lalani; Scott A North; François Patenaude; Denis Soulières; Phillippe Violette; Eric Winquist; Lori A Wood; Shaan Dudani; Ranjena Maloni; M Neil Reaume
Journal:  Can Urol Assoc J       Date:  2019-10       Impact factor: 1.862

6.  Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib.

Authors:  Chris Coppin
Journal:  Biologics       Date:  2010-05-25

7.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.

Authors:  Scott A North; Naveen Basappa; Joan Basiuk; Georg Bjarnason; Rodney Breau; Christina Canil; Daniel Heng; Michael A S Jewett; Anil Kapoor; Christian Kollmannsberger; Kylea Potvin; M Neil Reaume; J Dean Ruether; Peter Venner; Lori Wood
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

8.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Authors:  M Neil Reaume; Naveen S Basappa; Lori Wood; Anil Kapoor; Georg A Bjarnason; Normand Blais; Rodney H Breau; Christina Canil; Patrick Cheung; Henry J Conter; Sebastien J Hotte; Claudio Jeldres; Michael A S Jewett; Pierre I Karakiewicz; Christian Kollmannsberger; Francois Patenaude; Alan So; Denis Soulières; Peter Venner; Phillippe Violette; Pawel Zalewski; Heather Chappell; Scott A North
Journal:  Can Urol Assoc J       Date:  2017-10       Impact factor: 1.862

9.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.

Authors:  Scott North; Naveen Basappa; Georg Bjarnason; Normand Blais; Christina Canil; Daniel Heng; Jennifer Knox; Neil Reaume; Dean Ruether; Denis Soulières; Pawel Zalewski; Peter Black; Rodney H Breau; Rodney Breau; Michael Jewett; Anil Kapoor; Jean-Baptiste Lattouf; Ronald Moore; Ricardo Rendon; Gerald Todd; Edith Pituskin; Craig Gedye; Lori Wood
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.